Researchers develop an AI tool to predict cardiometabolic multimorbidity risk in type 2 diabetes, aiding early intervention and personalised care. Find out more.

When you buy through affiliate links in our content, we may earn a commission at no extra cost to you. Learn how our funding model works. By using this website you agree to our terms and conditions ...